Edwards Lifesciences
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, offering a range of products and solutions for individualized patient management.
Services
Edwards Lifesciences provides advanced medical solutions including heart valves and hemodynamic monitoring technologies. The company supports healthcare professionals with educational resources and training through the Edwards Learning Network. They offer reimbursement information and support for healthcare providers. Edwards Lifesciences is also deeply committed to sustainability and aims to achieve carbon neutrality by 2030. The company's philanthropic efforts are channeled through the Edwards Lifesciences Foundation, supporting various global initiatives and corporate giving programs.
Products
Edwards Lifesciences offers a diverse range of products focused on cardiac care and hemodynamic monitoring. Key products include the SAPIEN 3 Ultra RESILIA transcatheter heart valve, INSPIRIS RESILIA aortic valve, and the Acumen Hypotension Prediction Index (HPI) software. They provide advanced monitoring solutions such as the ForeSight tissue oximetry sensor, the HemoSphere monitoring platform, and the ClearSight cuff. Their product line also includes vascular solutions like Fogarty catheters and bovine patches, along with pediatric monitoring tools such as the PediaSat oximetry catheter and the VAMP Jr blood sampling system.
Sector
Edwards Lifesciences operates in the medical technology sector, specializing in cardiac care and hemodynamic monitoring. Their focus areas include developing innovative heart valves such as transcatheter and surgical heart valves, as well as providing critical care technologies. The company engages in clinical research and trials to advance medical knowledge and improve patient outcomes. Edwards Lifesciences contributes significantly to the broader healthcare industry by offering cutting-edge solutions that enhance patient care and surgical outcomes.
Innovative Solutions
Edwards Lifesciences has a strong track record of innovation in the medical technology field. Their development of the SAPIEN 3 Ultra RESILIA transcatheter heart valve and the INSPIRIS RESILIA aortic valve are notable examples of their commitment to long-term durability and advanced patient care. The Acumen Hypotension Prediction Index (HPI) software represents a significant advancement in detecting hemodynamic instability. Furthermore, their ForeSight tissue oximetry sensor and the HemoSphere advanced monitoring platform provide comprehensive insights for individualized patient management.
Clinical Research and Trials
Edwards Lifesciences is actively involved in clinical research and trials to advance medical knowledge and improve patient outcomes. Their research efforts focus on the development and validation of their innovative products, including heart valves and hemodynamic monitoring solutions. By participating in clinical trials, the company aims to provide evidence-based solutions that improve surgical and patient outcomes. Edwards Lifesciences' commitment to research is a cornerstone of their mission to enhance healthcare through continuous innovation and improvement.